Gabriela Smit

CRS:

BJMC

Role:

Administrative and Finance

Position:

Senior Research Service Analyst

Email:

gsmit1@jhmi.edu

Ms. Smit is Fiscal Operations Manager at the Johns Hopkins Center for Clinical Global Health Education. She is an experienced financial analyst with more than 2 decades of experience in finance and accounting and more than a decade of experience at Johns Hopkins University, where she has developed and managed federal and non-federal grants and contracts.
 
While at the CCGHE, she has assembled and managed several international teams of investigators from a number of institutions, including JHU, BJGMC (Lakshya, India), UVRI (Rakai, Uganda), and the National Institute for Research in Tuberculosis (Chennai, India). Ms. Smit provided strategic financial and administrative input to support the new JHU entities in India (JHIPL and JHIF). She manages all financial activities within the US, India and is the key contact for JHU-India collaborations with the NIH Grant Office, the JHU Central Administration, and the JHU SOM Office of Research Administration and Business Office.  In October 2016, she received the Johns Hopkins Department of Medicine Staff Recognition Award for outstanding service. Ms. Smit received a Bachelor of Science degree in Finance and Accounting from Babes-Bolyai University of Cluj-Napoca, Romania

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

Identification of Biomarkers That Can Predict Progression...

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...

Read More

The Pharmacokinetics, Safety and Acceptability of New...

PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More